Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 177 entries
View as:

A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01143090 Org: User:
Start: 08/31/10 End: - Due: -

Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00424528 Org: User:
Start: 12/31/06 End: 10/31/07 Due: 10/31/08

Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00073814 Org: User:
Start: 12/31/02 End: 06/30/03 Due: 06/30/04

Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT01401465 Org: User:
Start: 07/31/11 End: 11/30/11 Due: 11/30/12

Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00685529 Org: User:
Start: 04/30/05 End: 10/31/05 Due: 10/31/06

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00665600 Org: User:
Start: 02/28/02 End: 03/31/03 Due: 03/31/04

A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Phase: N/A Priority: Normal
NCT ID: NCT03391882 Org: User:
Start: 12/19/18 End: 08/11/21 Due: 08/11/22

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Phase: N/A Priority: Normal
NCT ID: NCT02734693 Org: User:
Start: 04/30/16 End: 02/28/17 Due: 02/28/18

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Phase: N/A Priority: Normal
NCT ID: NCT00868452 Org: User:
Start: 04/30/09 End: 01/31/12 Due: 01/31/13

A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00368030 Org: User:
Start: 01/31/04 End: 10/31/04 Due: 10/31/05

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Phase: N/A Priority: Normal
NCT ID: NCT04299880 Org: User:
Start: 02/24/20 End: 05/30/21 Due: 05/30/22

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02231723 Org: User:
Start: 08/31/14 End: 06/30/20 Due: 06/30/21

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00685841 Org: User:
Start: 02/28/02 End: 06/30/03 Due: 06/30/04

A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01656811 Org: User:
Start: 10/31/01 End: 07/31/02 Due: 07/31/03

Dasotraline Adult ADHD Study

Phase: N/A Priority: Normal
NCT ID: NCT02276209 Org: User:
Start: 12/31/14 End: 09/30/16 Due: 09/30/17

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Phase: N/A Priority: Normal
NCT ID: NCT03593915 Org: User:
Start: 08/29/18 End: 08/16/21 Due: 08/16/22

A Study of BBI503 in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01781455 Org: User:
Start: 02/29/12 End: 06/30/20 Due: 06/30/21

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00073840 Org: User:
Start: 12/31/02 End: 06/30/03 Due: 06/30/04

Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00684866 Org: User:
Start: 01/31/03 End: 07/31/03 Due: 07/31/04

A Study to Examine APL-130277 in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02228590 Org: User:
Start: 08/31/14 End: 11/24/14 Due: 11/24/15

A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00435279 Org: User:
Start: 06/30/07 End: 07/31/09 Due: 07/31/10

A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Phase: N/A Priority: Normal
NCT ID: NCT03416335 Org: User:
Start: 06/01/18 End: 12/20/22 Due: 12/20/23

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Phase: N/A Priority: Normal
NCT ID: NCT04623996 Org: User:
Start: 12/28/20 End: 04/27/21 Due: 04/27/22

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00685347 Org: User:
Start: 01/31/03 End: 06/30/03 Due: 06/30/04

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02483247 Org: User:
Start: 09/30/15 End: 05/31/19 Due: 05/31/20